Malignant transformation of a solitary fibrous tumor of the liver and intractable hypoglycemia

Sarcomas of the liver are rare. We report a case of intractable hypoglycemia secondary to a solitary fibrous tumor that underwent malignant transformation into a fibrosarcoma. A 70‐year‐old man presented with a hepatic mass and tumor‐associated hypoglycemia which was resistant to medical management....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of Hepato‐Biliary‐Pancreatic Surgery 2007-11, Vol.14 (6), p.595-599
Hauptverfasser: Chan, Gabriel, Horton, Peter J., Thyssen, Sandra, Lamarche, Marie, Nahal, Ayoub, Hill, David J., Marliss, Errol B., Metrakos, Peter
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Sarcomas of the liver are rare. We report a case of intractable hypoglycemia secondary to a solitary fibrous tumor that underwent malignant transformation into a fibrosarcoma. A 70‐year‐old man presented with a hepatic mass and tumor‐associated hypoglycemia which was resistant to medical management. Blood tests were remarkable only for elevated serum insulin‐like growth factor (IGF)‐2. The hypoglycemia resolved following resection of a solitary fibrous tumor surrounded by a high‐grade fibrosarcoma. Real time reverse transcriptase polymerase chain reaction (RT‐PCR) measured elevated levels of IGF2 mRNA in both the solitary fibrous tumor and the fibrosarcoma. Immunoblotting demonstrated a series of bands in the size range of pro‐IGF2. Unfortunately, disseminated metastases developed 1 year later, concurrent with a recurrence of hypoglycemia, marked again by elevation of serum IGF2. Solitary fibrous tumors of the liver have a real risk of malignant transformation. The severity of the tumor‐associated hypoglycemia may parallel the tumor burden and activity. The syndrome is the systemic effect of IGF2 secreted by the tumor. Surgery can treat the hypoglycemia syndrome and the underlying malignancy.
ISSN:0944-1166
1868-6982
1436-0691
DOI:10.1007/s00534-007-1210-0